{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:18:51Z","timestamp":1790839131277,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lung cancer patients frequently develop brain metastases (BM). Despite aggressive treatment including neurosurgery and external-radiotherapy, overall survival remains poor. There is a pressing need to further characterize factors in the microenvironment of BM that may confer resistance to radiotherapy (RT), such as hypoxia. Here, hypoxia was first evaluated in 28 biopsies from patients with non\u2011small cell lung cancer (NSCLC) BM, using CA-IX immunostaining. Hypoxia characterization (pimonidazole, CA-IX and HIF-1\u03b1) was also performed in different preclinical NSCLC BM models induced either by intracerebral injection of tumor cells (H2030-Br3M, H1915) into the cortex and striatum, or intracardial injection of tumor cells (H2030-Br3M). Additionally, [<jats:sup>18<\/jats:sup>F]-FMISO-PET and oxygen-saturation-mapping-MRI (SatO2-MRI) were carried out in the intracerebral BM models to further characterize tumor hypoxia and evaluate the potential of Hypoxia-image-guided-RT (HIGRT). The effect of RT on proliferation of BM ([<jats:sup>18<\/jats:sup>F]-FLT-PET), tumor volume and overall survival was determined. We showed that hypoxia is a major yet heterogeneous feature of BM from lung cancer both preclinically and clinically. HIGRT, based on hypoxia heterogeneity observed between cortical and striatal metastases in the intracerebrally induced models, showed significant potential for tumor control and animal survival. These results collectively highlight hypoxia as a hallmark of BM from lung cancer and the value of HIGRT in better controlling tumor growth.<\/jats:p>","DOI":"10.1038\/s41598-021-90662-0","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T10:16:36Z","timestamp":1622110596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Aur\u00e9lien","family":"Corroyer-Dulmont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Teulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bazille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Letissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Divoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9ziane","family":"Ibaziz\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Guillouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Perrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola R.","family":"Sibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Chapon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"90662_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000326","author":"R Rud\u00e0","year":"2016","unstructured":"Rud\u00e0, R., Franchino, F. & Soffietti, R. Treatment of brain metastasis: Current status and future directions. Curr. Opin. Oncol. https:\/\/doi.org\/10.1097\/CCO.0000000000000326 (2016).","journal-title":"Curr. Opin. Oncol."},{"key":"90662_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.nurt.2009.04.012","volume":"6","author":"T Ranjan","year":"2009","unstructured":"Ranjan, T. & Abrey, L. E. Current management of metastatic brain disease. Neurotherapeutics 6, 598\u2013603 (2009).","journal-title":"Neurotherapeutics"},{"key":"90662_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","volume":"31","author":"P Sacks","year":"2020","unstructured":"Sacks, P. & Rahman, M. Epidemiology of brain metastases. Neurosurg. Clin. N. Am. 31, 481\u2013488 (2020).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"90662_CR4","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.4103\/2152-7806.111301","volume":"4","author":"E McTyre","year":"2013","unstructured":"McTyre, E., Scott, J. & Chinnaiyan, P. Whole brain radiotherapy for brain metastasis. Surg. Neurol. Int. 4, S236\u2013S244 (2013).","journal-title":"Surg. Neurol. Int."},{"key":"90662_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown, P. D. et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases. JAMA 316, 401 (2016).","journal-title":"JAMA"},{"key":"90662_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0733-8619(02)00031-2","volume":"21","author":"NE Cross","year":"2003","unstructured":"Cross, N. E. & Glantz, M. J. Neurologic complications of radiation therapy. Neurol. Clin. 21, 249\u2013277 (2003).","journal-title":"Neurol. Clin."},{"key":"90662_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jrr\/rrw007","volume":"57","author":"MR Horsman","year":"2016","unstructured":"Horsman, M. R. & Overgaard, J. The impact of hypoxia and its modification of the outcome of radiotherapy. J. Radiat. Res. 57, 1\u20139 (2016).","journal-title":"J. Radiat. Res."},{"key":"90662_CR8","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1111\/nan.12185","volume":"41","author":"AS Berghoff","year":"2015","unstructured":"Berghoff, A. S. et al. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: Analysis of 639 cases. Neuropathol. Appl. Neurobiol. 41, e41\u2013e55 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"90662_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00066-014-0639-8","volume":"190","author":"AS Berghoff","year":"2014","unstructured":"Berghoff, A. S. et al. Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases. Strahlenther. Onkol. 190, 676\u2013685 (2014).","journal-title":"Strahlenther. Onkol."},{"key":"90662_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20144-w","volume":"11","author":"RY Ebright","year":"2020","unstructured":"Ebright, R. Y. et al. HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"90662_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol, A. S. et al. Brain metastases. Nat. Rev. Dis. Prim. 5, 5 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"90662_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10637-014-0173-7","volume":"33","author":"GS Falchook","year":"2015","unstructured":"Falchook, G. S. et al. A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer. Investig. New Drugs 33, 177\u2013186 (2015).","journal-title":"Investig. New Drugs"},{"key":"90662_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/1535-7163.MCT-14-0950","volume":"14","author":"D Kanojia","year":"2015","unstructured":"Kanojia, D. et al. III-Tubulin regulates breast cancer metastases to the brain. Mol. Cancer Ther. 14, 1152\u20131161 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"90662_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1515\/hsz-2012-0318","volume":"394","author":"A Corroyer-Dulmont","year":"2013","unstructured":"Corroyer-Dulmont, A. et al. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): A PET study in two experimental models of human glioma. Biol. Chem. 394, 529\u2013539 (2013).","journal-title":"Biol. Chem."},{"key":"90662_CR15","first-page":"2584","volume":"37","author":"S Valable","year":"2017","unstructured":"Valable, S. et al. Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain. JCBFM 37, 2584\u20132597 (2017).","journal-title":"JCBFM"},{"key":"90662_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fmed.2015.00057","volume":"2","author":"A Corroyer-Dulmont","year":"2015","unstructured":"Corroyer-Dulmont, A. et al. Imaging modalities to assess oxygen status in glioblastoma. Front. Med. 2, 57 (2015).","journal-title":"Front. Med."},{"key":"90662_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.radonc.2011.07.029","volume":"101","author":"K Hendrickson","year":"2011","unstructured":"Hendrickson, K. et al. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. Radiother. Oncol. 101, 369\u2013375 (2011).","journal-title":"Radiother. Oncol."},{"issue":"Suppl 2","key":"90662_CR18","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/j.lungcan.2004.07.967","volume":"45","author":"W Schuette","year":"2004","unstructured":"Schuette, W. Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 45(Suppl 2), S253\u2013S257 (2004).","journal-title":"Lung Cancer"},{"key":"90662_CR19","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1200\/JCO.2005.03.145","volume":"23","author":"CJ Langer","year":"2005","unstructured":"Langer, C. J. & Mehta, M. P. Current management of brain metastases, with a focus on systemic options. J. Clin. Oncol. 23, 6207\u20136219 (2005).","journal-title":"J. Clin. Oncol."},{"key":"90662_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3677-5","author":"L Bekaert","year":"2017","unstructured":"Bekaert, L. et al. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. Eur. J. Nucl. Med. Mol. Imaging https:\/\/doi.org\/10.1007\/s00259-017-3677-5 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"90662_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-811161-1.00001-3","volume":"149","author":"QT Ostrom","year":"2018","unstructured":"Ostrom, Q. T., Wright, C. H. & Barnholtz-Sloan, J. S. Brain metastases: Epidemiology. Handb. Clin. Neurol. 149, 3\u201323 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"90662_CR22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","volume":"26","author":"LH Gray","year":"1953","unstructured":"Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S. & Scott, O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26, 638\u2013648 (1953).","journal-title":"Br. J. Radiol."},{"key":"90662_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13000-016-0495-1","volume":"11","author":"MR Ambrosio","year":"2016","unstructured":"Ambrosio, M. R. et al. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer. Diagn. Pathol. 11, 45 (2016).","journal-title":"Diagn. Pathol."},{"key":"90662_CR24","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/bjc.2011.147","volume":"104","author":"AM Jubb","year":"2011","unstructured":"Jubb, A. M. et al. Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. Br. J. Cancer 104, 1877\u20131881 (2011).","journal-title":"Br. J. Cancer"},{"key":"90662_CR25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/neuonc\/nos216","volume":"14","author":"MA Proescholdt","year":"2012","unstructured":"Proescholdt, M. A. et al. Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro. Oncol. 14, 1357\u20131366 (2012).","journal-title":"Neuro. Oncol."},{"key":"90662_CR26","first-page":"188","volume":"50","author":"D-F Wei","year":"2019","unstructured":"Wei, D.-F., Tang, M.-K., Liu, Y., Zhang, C.-Y. & Qin, L.-J. Effect of hypoxia inducible factor-1 alpha on brain metastasis from lung cancer and its mechanism. Sichuan Da Xue Xue Bao Yi Xue Ban 50, 188\u2013192 (2019).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"90662_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10585-018-9929-3","volume":"35","author":"JHE Baker","year":"2018","unstructured":"Baker, J. H. E. et al. Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: Role of the tumor microenvironment. Clin. Exp. Metastasis 35, 691\u2013705 (2018).","journal-title":"Clin. Exp. Metastasis"},{"key":"90662_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-18-2168","volume":"79","author":"KJ Ray","year":"2019","unstructured":"Ray, K. J. et al. Tumor pH and protein concentration contribute to the signal of amide proton transfer magnetic resonance imaging. Cancer Res. 79, 1343\u20131352 (2019).","journal-title":"Cancer Res."},{"key":"90662_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1593\/tlo.12109","volume":"5","author":"M Perera","year":"2012","unstructured":"Perera, M. et al. In vivo magnetic resonance imaging for investigating the development and distribution of experimental brain metastases due to breast cancer. Transl. Oncol. 5, 217\u2013225 (2012).","journal-title":"Transl. Oncol."},{"key":"90662_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz023","author":"TK Yanagihara","year":"2019","unstructured":"Yanagihara, T. K. et al. A low percentage of metastases in deep brain and temporal lobe structures. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noz023 (2019).","journal-title":"Neuro Oncol."},{"key":"90662_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.compbiomed.2018.02.004","volume":"95","author":"O Charron","year":"2018","unstructured":"Charron, O. et al. Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network. Comput. Biol. Med. 95, 43\u201354 (2018).","journal-title":"Comput. Biol. Med."},{"key":"90662_CR32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","volume":"21","author":"F Pietrocola","year":"2015","unstructured":"Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F. & Kroemer, G. Acetyl coenzyme A: A central metabolite and second messenger. Cell Metab. 21, 805\u2013821 (2015).","journal-title":"Cell Metab."},{"key":"90662_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2015.02.002","volume":"21","author":"A Moussaieff","year":"2015","unstructured":"Moussaieff, A. et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392\u2013402 (2015).","journal-title":"Cell Metab."},{"key":"90662_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.molcel.2014.06.020","volume":"55","author":"C Shan","year":"2014","unstructured":"Shan, C. et al. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol. Cell 55, 552\u2013565 (2014).","journal-title":"Mol. Cell"},{"key":"90662_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2014.04.046","volume":"158","author":"G Sutendra","year":"2014","unstructured":"Sutendra, G. et al. A nuclear pyruvate dehydrogenase complex is important for the generation of Acetyl-CoA and histone acetylation. Cell 158, 84\u201397 (2014).","journal-title":"Cell"},{"key":"90662_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell Histone acetylation. Cell Metab. 20, 306\u2013319 (2014).","journal-title":"Cell Metab."},{"key":"90662_CR37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo, T. et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603\u20131614 (2014).","journal-title":"Cell"},{"key":"90662_CR38","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1038\/s41388-020-01432-7","volume":"39","author":"Q Wei","year":"2020","unstructured":"Wei, Q., Qian, Y., Yu, J. & Wong, C. C. Metabolic rewiring in the promotion of cancer metastasis: Mechanisms and therapeutic implications. Oncogene 39, 6139\u20136156 (2020).","journal-title":"Oncogene"},{"key":"90662_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0137204","volume":"10","author":"YY Jung","year":"2015","unstructured":"Jung, Y. Y., Kim, H. M. & Koo, J. S. Expression of lipid metabolism-related proteins in metastatic breast cancer. PLoS ONE 10, 1\u201313 (2015).","journal-title":"PLoS ONE"},{"key":"90662_CR40","first-page":"885","volume":"34","author":"D Groshar","year":"1993","unstructured":"Groshar, D. et al. Imaging tumor hypoxia and tumor perfusion. J. Nucl. Med. 34, 885\u2013888 (1993).","journal-title":"J. Nucl. Med."},{"key":"90662_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10585-014-9675-0","volume":"31","author":"AS Berghoff","year":"2014","unstructured":"Berghoff, A. S. et al. \u03b1v\u03b23, \u03b1v\u03b25 and \u03b1v\u03b26 integrins in brain metastases of lung cancer. Clin. Exp. Metastasis 31, 841\u2013851 (2014).","journal-title":"Clin. Exp. Metastasis"},{"key":"90662_CR42","doi-asserted-by":"crossref","unstructured":"Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13. Drugs in R&D 6\u00a0178-85 (2005).","DOI":"10.2165\/00126839-200506030-00007"},{"key":"90662_CR43","doi-asserted-by":"publisher","first-page":"a037242","DOI":"10.1101\/cshperspect.a037242","volume":"10","author":"AE Yuzhalin","year":"2020","unstructured":"Yuzhalin, A. E. & Yu, D. Brain metastasis organotropism. Cold Spring Harb. Perspect. Med. 10, a037242 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"90662_CR44","first-page":"1773","volume":"33","author":"H Yamazaki","year":"2013","unstructured":"Yamazaki, H. et al. Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: A preliminary feasibility report. Anticancer Res. 33, 1773\u20131776 (2013).","journal-title":"Anticancer Res."},{"key":"90662_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2004.00.1768","volume":"24","author":"JH Suh","year":"2006","unstructured":"Suh, J. H. et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J. Clin. Oncol. 24, 106\u2013114 (2006).","journal-title":"J. Clin. Oncol."},{"key":"90662_CR46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.bjc.6603169","volume":"94","author":"B Stea","year":"2006","unstructured":"Stea, B. et al. Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases. Br. J. Cancer 94, 1777\u20131784 (2006).","journal-title":"Br. J. Cancer"},{"key":"90662_CR47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.21037\/tlcr-20-500","volume":"9","author":"L Peng","year":"2020","unstructured":"Peng, L. et al. The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer. Transl. Lung Cancer Res. 9, 745\u2013760 (2020).","journal-title":"Transl. Lung Cancer Res."},{"key":"90662_CR48","doi-asserted-by":"crossref","unstructured":"Ma, J. et al. 4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1\u03b1 and Caveolin-1. Cell Death Dis. 7, e2372 (2016).","DOI":"10.1038\/cddis.2016.281"},{"key":"90662_CR49","unstructured":"Liu, Y., Jia, Y. Sen & Qin, L. J. Role of microRNA-155 in brain metastasis of hypoxic lung cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 50, 835-839 (2019)."},{"key":"90662_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1470-7330-14-8","volume":"14","author":"R Zakaria","year":"2014","unstructured":"Zakaria, R. et al. The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging 14, 8 (2014).","journal-title":"Cancer Imaging"},{"key":"90662_CR51","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiol.12112621","volume":"265","author":"B Lemasson","year":"2012","unstructured":"Lemasson, B. et al. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: Effect of an antiangiogenic treatment on a gliosarcoma model. Radiology 265, 743\u2013752 (2012).","journal-title":"Radiology"},{"key":"90662_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/0284186X.2011.599815","volume":"51","author":"I Toma-Dasu","year":"2012","unstructured":"Toma-Dasu, I. et al. Dose prescription and treatment planning based on FMISO-PET hypoxia. Acta Oncol. 51, 222\u2013230 (2012).","journal-title":"Acta Oncol."},{"key":"90662_CR53","first-page":"2270","volume":"37","author":"A Chakhoyan","year":"2016","unstructured":"Chakhoyan, A. et al. Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models. JCBFM 37, 2270\u20132282 (2016).","journal-title":"JCBFM"},{"key":"90662_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2019.00117","volume":"6","author":"M G\u00e9rard","year":"2019","unstructured":"G\u00e9rard, M. et al. Hypoxia imaging and adaptive radiotherapy: A state-of-the-art approach in the management of glioma. Front. Med. 6, 1 (2019).","journal-title":"Front. Med."},{"key":"90662_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0360-3016(99)00117-0","volume":"44","author":"JA Antolak","year":"1999","unstructured":"Antolak, J. A. & Rosen, I. I. Planning target volumes for radiotherapy: How much margin is needed?. Int. J. Radiat. Oncol. Biol. Phys. 44, 1165\u20131170 (1999).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"90662_CR56","first-page":"1","volume":"34","author":"L Bekaert","year":"2016","unstructured":"Bekaert, L., Emery, E., Levallet, G. & Lechapt-Zalcman, E. Histopathologic diagnosis of brain metastases: Current trends in management and future considerations. Brain Tumor Pathol. 34, 1\u201312 (2016).","journal-title":"Brain Tumor Pathol."},{"key":"90662_CR57","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00259-015-3225-0","volume":"43","author":"A Corroyer-Dulmont","year":"2016","unstructured":"Corroyer-Dulmont, A. et al. Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma. Eur. J. Nucl. Med. Mol. Imaging 43, 682\u2013694 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"90662_CR58","first-page":"781","volume":"38","author":"S Valable","year":"2011","unstructured":"Valable, S. et al. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model. Nucl. Med. Biol. 38, 781\u2013793 (2011).","journal-title":"Nucl. Med. Biol."},{"key":"90662_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/neuonc\/nos260","volume":"15","author":"A Corroyer-Dulmont","year":"2013","unstructured":"Corroyer-Dulmont, A. et al. Detection of glioblastoma response to temozolomide combined with bevacizumab based on \u03bcMRI and \u03bcPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy. Neuro Oncol. 15, 41\u201356 (2013).","journal-title":"Neuro Oncol."},{"key":"90662_CR60","doi-asserted-by":"crossref","unstructured":"Franken, N. a P., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315-9 (2006).","DOI":"10.1038\/nprot.2006.339"},{"key":"90662_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0360-3016(94)90432-4","volume":"29","author":"R Rampling","year":"1994","unstructured":"Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A. & Workman, P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29, 427\u2013431 (1994).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"90662_CR62","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tibtech.2014.09.006","volume":"32","author":"MB Byrne","year":"2014","unstructured":"Byrne, M. B., Leslie, M. T., Gaskins, H. R. & Kenis, P. J. A. Methods to study the tumor microenvironment under controlled oxygen conditions. Trends Biotechnol. 32, 556\u2013563 (2014).","journal-title":"Trends Biotechnol."},{"key":"90662_CR63","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.18632\/oncotarget.2937","volume":"6","author":"EA P\u00e9r\u00e8s","year":"2015","unstructured":"P\u00e9r\u00e8s, E. A. et al. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe. Oncotarget 6, 2101\u20132119 (2015).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90662-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T06:26:26Z","timestamp":1699079186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90662"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90662-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11239"}}